CSL Plasma Offering $40,000 for Breakthrough Ideas to Help Plasma Shortage


Immunoglobulin (Ig) replacement therapy company, CSL Plasma, has sent out a challenge to help them with their plasma supply--offering $40,000 and mentorship to the person or team who can help. They are partnering with Australian start-up incubator Cicada Innovations. 

With the ongoing plasma supply shortage, which has been exacerbated by the COVID-19 pandemic, CSL Plasma wants to enhance its current processes to collect more Ig from every liter of donated plasma. 

To win, individuals or team entrants only need to have a good idea. There is no requirement for the idea to be a fully functioning product. Applications close on May 25.

Learn more about this opportunity.

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

Busting common plasma donation myths


Misconceptions about plasma donation, such as that it is bad for your health, lead to undue misapprehensions.
Read More

How donated plasma treats trauma and shock


Studies show that giving patients plasma immediately after a traumatic injury improves survival rates significantly.
Read More

Understanding the plasma ecosystem from donor to patient


Find out how plasma is collected, what happens after it’s collected, and who ultimately benefits from plasma-derived medicinal products (PDMPs).
Read More

How plasma saved lives through the ages, from 1918 to WWII to today


Both convalescent plasma and plasma-based therapies have been around for some time, though many people are still unfamiliar with their history.
Read More

Science-based policies boost plasma donation globally


Science is driving global advancements in policy and allowing more people around the world to donate plasma while ensuring the safety of donors and the plasma collected.
Read More

How plasma-based therapies treat hemophilia


Plasma has been used to treat bleeding disorders like hemophilia since the 1950s, and is still one of the most effective treatment options for patients.
Read More